Thomas L. Mindt

4.4k citations

86 papers · 3.4k indexed · h-index 33

Impact in

Radiology, Nuclear Medicine and Imaging top 0.5%
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
Organic Chemistry top 1%
- Click Chemistry and Applications

Papers in

Radiology, Nuclear Medicine and Imaging 49
- Radiopharmaceutical Chemistry and Applications 45
- Medical Imaging Techniques and Applications 11
- Monoclonal and Polyclonal Antibodies Research 10
Oncology 40
- Peptidase Inhibition and Analysis 33

Co-authors: Roger Schibli Harriet Struthers Ibai E. Valverde Gilles Gasser Sandra Vomstein Andreas Bauman Kathlyn A. Parker Dirk Tourwé
Journals: European Journal of Nuclear Medicine and Molecular Imaging (7 papers)ChemMedChem (6 papers)Nuclear Medicine and Biology (6 papers)Bioconjugate Chemistry (5 papers)Journal of Medicinal Chemistry (5 papers)
Partner nations: Switzerland Austria Netherlands

In The Last Decade

Thomas L. Mindt

84 papers receiving 3.4k citations

Peers

Countries citing papers authored by Thomas L. Mindt

Since Specialization

Citations

This map shows the geographic impact of Thomas L. Mindt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas L. Mindt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas L. Mindt more than expected).

Fields of papers citing papers by Thomas L. Mindt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas L. Mindt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas L. Mindt. The network helps show where Thomas L. Mindt may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas L. Mindt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas L. Mindt Line = papers co-authored together Thomas L. Mindt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Site-Selectively Functionalized Albumin with DFOMaleimide for ⁸⁹Zr-Radiolabeling Yields a Metabolically Stable PET Probe that Enables Late Time-Point Tumor Imaging in Mice Journal of Medicinal Chemistry* ·Hohenberger, Theresa Balber, Hemma Schueffl, Xi Wang, 郭俊义, Yi Jer Hsieh, Marie Brandt, Thomas Wanek, Markus Mitterhauser, Christian R. Kowol, Thomas L. Mindt, Petra Heffeter	2025	0
2	Amide-to-Triazole Switch in Somatostatin-14-Based Radioligands: Impact on Receptor Affinity and In Vivo Stability Pharmaceutics ·F A Olopade, N. Woltman, Pia Gjellerup, García de La Torre Rivera María Pilar, 誠一林, Marie Brandt, Wolfgang Kandioller, Θεοδοσία Μάινα, Berthold A. Nock, Thomas L. Mindt	2024	2
3	Synthesis and preclinical evaluation of BOLD-100 radiolabeled with ruthenium-97 and ruthenium-103 Dalton Transactions ·Liat Feraru, Theresa Balber, Petra Heffeter, Christoph Denk, 立神勝則, U. Köster, CECIL H. FOX, Leidy J. Fernández C., Marie Brandt, Férid Haddad, Johannes H. Sterba, Wolfgang Kandioller, Markus Mitterhauser, Marcus Hacker, Bernhard K. Keppler, Thomas L. Mindt	2024	7
4	Combination of the amide‐to‐triazole substitution strategy with alternative structural modifications for the metabolic stabilization of tumor‐targeting, radiolabeled peptides Journal of Peptide Science ·F A Olopade, Stijn Heyman, Gonçalo Daniel Almeida Santos, 誠一林, Berthold A. Nock, Θεοδοσία Μάινα, Thomas L. Mindt	2024	1
5	Towards Ruthenium(II)‐Rhenium(I) Binuclear Complexes as Photosensitizers for Photodynamic Therapy ChemBioChem ·Филипп Вохминцев, Lianghu Zhang, Olivia Marx, Olivier Blacque, Thomas L. Mindt, Kevin Cariou, Gilles Gasser	2023	9
6	Quality Assurance Investigations and Impurity Characterization during Upscaling of [177Lu]Lu-PSMAI&T Molecules ·M. R. Mitchell, Janette Cilliers, Stephan Witoszynskyj, Bar El Yasmin, Lukas Nics, 祐司白取, I. R. MCFAYDEN, Thomas L. Mindt, Marcus Hacker, Wolfgang Wadsak, Marie Brandt, Markus Mitterhauser	2023	3
7	Straightforward Synthesis of DFO* ‐ An Octadentate Chelator for Zirconium‐89 ChemMedChem ·F A Olopade, Hohenberger, Muh. Farhan Hidayat, Vijoykumar Singh, Thomas L. Mindt, 誠一林	2023	2
8	Synthesis and Preclinical Evaluation of Radiolabeled [103Ru]BOLD-100 Pharmaceutics ·Liat Feraru, Marie Brandt, Theresa Balber, А. А. Шабанов, Zeynep Talip, Mohsen Gholipour, Petra Heffeter, Wolfgang Kandioller, Nicholas P. van der Meulen, Markus Mitterhauser, Marcus Hacker, Bernhard K. Keppler, Thomas L. Mindt	2023	4
9	Theranostics with photodynamic therapy for personalized medicine: to see and to treat Theranostics ·邹锦钢, María Laura Estrada Murillo, Thomas L. Mindt, Gilles Gasser	2023	24
10	EANM guideline on quality risk management for radiopharmaceuticals European Journal of Nuclear Medicine and Molecular Imaging ·Nic Gillings, G TRALLORI, Martin Béhé, Clemens Decristoforo, Philip H. Elsinga, Xiwei Hao, Cornelia Degeratu, Petra Kolenc Peitl, Jacek Koziorowski, M. A. Chaney, Thomas L. Mindt, Meltem Ocak, Marianne Patt, Sergio Todde, فطيمة الزهراء حوتية	2022	19
11	Development and in vitro evaluation of new bifunctional 89Zr-chelators based on the 6-amino-1,4-diazepane scaffold for immuno-PET applications Nuclear Medicine and Biology ·Leeseul Lee, Kirsten Bär, Thomas L. Mindt, Gilles Gasser, Frank Rösch	2021	8
12	1,4-Disubstituted 1,2,3-Triazoles as Amide Bond Surrogates for the Stabilisation of Linear Peptides with Biological Activity Molecules ·García de La Torre Rivera María Pilar, Wolfgang Kandioller, Thomas L. Mindt	2020	46
13	Manganese in PET imaging: Opportunities and challenges Journal of Labelled Compounds and Radiopharmaceuticals ·Marie Brandt, Jens Cardinale, Ivo Rausch, Thomas L. Mindt	2019	28
14	An Overview of PET Radiochemistry, Part 2: Radiometals Journal of Nuclear Medicine ·Marie Brandt, Jens Cardinale, Margaret L. Aulsebrook, Gilles Gasser, Thomas L. Mindt	2018	98
15	Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight Nuclear Medicine and Biology ·Heinz H. Coenen, Antony D. Gee, Michael J. Adam, Gunnar Antoni, Cathy S. Cutler, Yasuhisa Fujibayashi, Jae Min Jeong, Robert H. Mach, Thomas L. Mindt, Victor W. Pike, Albert D. Windhorst	2017	154
16	Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors Nuclear Medicine and Biology ·Θεοδοσία Μάινα, Aikaterini Kaloudi, Ibai E. Valverde, Thomas L. Mindt, Berthold A. Nock	2017	14
17	Guidance on validation and qualification of processes and operations involving radiopharmaceuticals EJNMMI Radiopharmacy and Chemistry ·Sergio Todde, Petra Kolenc Peitl, Philip H. Elsinga, Jacek Koziorowski, Vincenzo Ferrari, Kyoung-Beom Kim, G TRALLORI, Marianne Patt, Thomas L. Mindt, Martin Béhé	2017	33
18	1,2,3‐Triazoles as Amide Bond Mimics: Triazole Scan Yields Protease‐Resistant Peptidomimetics for Tumor Targeting Angewandte Chemie International Edition ·Ibai E. Valverde, Andreas Bauman, SunilMaragowdanahalli Gurupadaswamy, Sandra Vomstein, Martin A. Walter, Thomas L. Mindt	2013	153
19	Metal chelating systems synthesized using the copper(i) catalyzed azide-alkynecycloaddition Dalton Transactions ·Harriet Struthers, Thomas L. Mindt, Roger Schibli	2009	356
20	A Click Approach to Structurally Diverse Conjugates Containing a Central Di‐1,2,3‐triazole Metal Chelate ChemMedChem ·Thomas L. Mindt, Christian Schweinsberg, Luc Brans, Adelheid Hagenbach, Ulrich Abram, Dirk Tourwé, Elisa García‐Garayoa, Roger Schibli	2009	50

About Thomas L. Mindt

Thomas L. Mindt is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Organic Chemistry, Radiation and Pharmaceutical Science, having authored 86 papers that have together received 3.4k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (45 papers), Peptidase Inhibition and Analysis (33 papers), Click Chemistry and Applications (25 papers), Chemical Synthesis and Analysis (20 papers), Medical Imaging Techniques and Applications (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Neuroendocrine Tumor Research Advances (8 papers) and Radioactive Decay and Measurement Techniques (7 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.6k citations), Organic Chemistry (1.5k citations), Oncology (952 citations), Pharmaceutical Science (114 citations) and Molecular Biology (1.0k citations). Thomas L. Mindt has collaborated with scholars based in Switzerland, Austria and Netherlands. Frequent co-authors include Roger Schibli, Harriet Struthers, Ibai E. Valverde, Gilles Gasser, Sandra Vomstein, Andreas Bauman, Kathlyn A. Parker, Dirk Tourwé, Luc Brans and Bernhard Spingler. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, ChemMedChem, Nuclear Medicine and Biology, Bioconjugate Chemistry and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact